| Literature DB >> 35408857 |
Joanna Potaś1, Katarzyna Winnicka1.
Abstract
Polyelectrolyte multilayers (PEMs) represent a group of polyelectrolyte complex (PEC)-based materials widely investigated in the biomedical and pharmaceutical sciences. Despite the unflagging popularity of the aforementioned systems in tissue engineering, only a few updated scientific reports concerning PEM potential in drug administration can be found. In fact, PEM coatings are currently recognized as important tools for functionalizing implantable scaffolds; however, only a small amount of attention has been given to PEMs as drug delivery materials. Scientific reports on PEMs reveal two dominant reasons for the limited usability of multilayers in pharmaceutical technology: complex and expensive preparation techniques as well as high sensitivity of interacting polyelectrolytes to the varieties of internal and external factors. The aim of this work was to analyze the latest approaches, concerning the potential of PEMs in pharmacy, chemical technology, and (primarily) tissue engineering, with special attention given to possible polymer combinations, technological parameters, and physicochemical characteristics, such as hydrophilicity, adhesive and swelling properties, and internal/external structures of the systems formed. Careful recognition of the above factors is crucial in the development of PEM-based drug delivery materials.Entities:
Keywords: drug delivery material; multifunctional polymeric material; polyelectrolyte complex; polyelectrolyte multilayer film
Mesh:
Substances:
Year: 2022 PMID: 35408857 PMCID: PMC8998809 DOI: 10.3390/ijms23073496
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The applicability of polyelectrolyte multilayers (PEMs) in the biomedical and pharmaceutical fields.
Figure 2Site- and polymer-dominated diffusion mechanisms of PEM formation.
Physicochemical characteristics of the selected polyelectrolytes used in PEM preparation [3,25,26,27,28].
| Polyelectrolytes | Physicochemical Characteristics |
|---|---|
|
| |
|
| |
| Chitosan |
Linear polysaccharide composed of β-(1,4)-linked D-glucosamine and N-acetyl-D-glucosamine units. Product of chitin deacetylation derived from the exoskeleton of crustaceans, insect cuticles, or fungi. Available in a wide range of deacetylation degrees and molecular weights. The presence of amine groups determines its polycationic character. Poorly soluble at a pH above 6.5. Multifunctional performance covers antifungal, antibacterial, anti-inflammatory, and healing behaviors of the polymer. |
|
| |
| Eudragit E |
Cationic polymer based on (dimethylamino)ethyl methacrylate and other neutral methacrylic acid esters. Soluble at pH below 5. Available in the form of an organic solution (Eudragit E 12.5), granules (Eudragit E 100), or powder (Eudragit E PO). Commonly utilized as film coating for drug dosage forms. |
| Poly(4-vinylpyridine) |
Hydrophobic polymer with polycationic character at pH below 4.7. |
| Poly-L-lysine |
Synthetic amino acid with positively charged hydrophilic amino groups. Widely used as a coating agent to support cell adhesion by altering surface charge in culture. |
|
| |
|
| |
| Sodium alginate |
Linear polysaccharide composed of 1,4-linked β-D-mannuronic acid and α-L-guluronic acid units with anionic carboxylic acid groups. Hydrophilic derivative of alginic acid derived from marine brown algae by alkali extraction. Slowly soluble in water, forming a viscous colloidal solution susceptible to concentration, pH, temperature, or the presence of metal ions; while at a pH below 3, alginic acid precipitates, a pH above 10 induces viscosity decrease. Widely used as a thickening, suspending and stabilizing agent. |
| Hyaluronic acid |
Linear polysaccharide composed of α-(1,4)-D-glucuronic acid and β-(1,3)-N-acetyl-D-glucosamine units with carboxylic acid groups. Derived from animal tissues or produced via bacterial fermentation with genetically modified strains. One of the major constituents of the skin and extracellular tissues. Determines cell growth, migration, and differentiation. Characterized by significant moisture retention and beneficial viscoelasticity. |
| Heparin |
Mucopolysaccharide consisted of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. Obtained from mucosal tissues, e.g., porcine intestines or bovine lungs. Highly acidic polymer. Used as an anticoagulant. |
| Chondroitin sulfate |
Sulfated glycosaminoglycan composed of the units of β-(1,4)-D-glucuronic acid and β-(1,3)-N-acetyl-D-galactosamine. One of the components of the cartilage and extracellular matrix. Widely used in combination with glucosamine in the therapy of osteoarthritis. Regulates adhesion, proliferation, and differentiation of cells. |
| Carrageenans |
Potassium, sodium, calcium, magnesium, or ammonium sulfate esters of galactose and 3,6-anhydrogalactose copolymers obtained from red seaweeds. There are three types of carrageenans: kappa (κ)-, iota (ι)-, and lambda (λ)-carrageenans, with different numbers and positions of negatively charged ester sulfate groups. Various susceptibilities to interpolymer complexation is noted (depending on the isomer type). The polymers are recommended for oropharyngeal and buccal drug dosage form development because of high mucoadhesion properties. Widely used as stabilizing and thickening agents (substitute of gelatin). |
| Tannic acid |
Plant polyphenol mostly derived from Caesalpinia spinosa, Rhus semialata, R. coriaria, and Quercus infectoria. Mixture of polygalloyl glucoses or polygalloyl quinic acid esters. Contains no carboxyl groups; weakly acidic character results from the presence of phenolic hydroxyl groups. Hydroxyl groups determine high water-solubility. Used for the therapy of diarrhea, skin burns, and rectal disorders. |
| Poly(γ–glutamic acid) |
Naturally occurring, water-soluble, biodegradable, and non-toxic poly amino acid. Produced by Stimulates immune activity. Utilized in chemotherapeutic agent delivery. |
| Xanthan gum |
High molecular weight polysaccharide composed of D-glucose, D-mannose, and D-glucuronic acid monomers obtained from Easily modified due to the presence of carboxylic acid and hydroxyl groups. Viscosity and mucoadhesion enhancer; stabilizing and prolonged release agent in oral and topical products. Stable over a wide range of pHs and temperatures. |
| Karaya gum |
Product obtained from the exudate of Relatively stable at acidic pH and thermolabile. Adhesive, emulsifier, suspension, and tablet agent. |
|
| |
| Hypromellose acetate succinate |
Mixture of acetic acid and mono-succinic acid esters of hydroxypropylmethyl cellulose, obtained by the esterification of hypromellose with acetic anhydride and succinic anhydride. Enteric polymer soluble at a pH above 5.5 due to the presence of carboxyl groups. Creates clear or turbid solutions in buffers with pH above 4.5. Controlled-release, enteric-coating, or solubility-enhancing agent. Easily subjected to hydrolysis upon exposure to moisture. |
| Carboxymethylcellulose sodium |
Sodium salt of poly(carboxymethyl) ether of cellulose. Easily soluble in water; forming transparent, colloidal solutions. Incompatible with ethanol 96%, strongly acidic solutions (pH < 2), metal salts, or xanthan gum. Viscosity-enhancing agent for oral and topical products. Because of its beneficial bioadhesive and water-uptake properties, it is utilized for wound healing. Drug- and cyto-protective agent. |
| β-cyclodextrins |
Represent a family of cyclic glucopyranose oligomers derived from hydrolyzed starch via enzymatic degradation with a lipophilic interior cavity and a hydrophilic exterior. Consist of seven α-(1,4)-linked glucopyranose units. Limited water-solubility (1:50 at 20 °C, 1:20 at 50 °C). Form inclusion complexes for oral administration, providing physicochemical stability of the drug or taste-masking effect. |
The utility of PEMs as drug delivery systems with regard to the polycation and polyanion used, model drugs, and potential applicability.
| Polycation | Polyanion | Active Substance | Potential Applicability | Reference |
|---|---|---|---|---|
| Chitosan | Sodium alginate | Tamoxifen | Patches, injectable gel-like films | Criado-Gonzalez et al. [ |
| Hyaluronic acid/sodium hyaluronate | Doxorubicin hydrochloride, Fluorescein isothiocyanate, Ovalbumin | Anticancer rapidly-disintegrating films | Sun et al. [ | |
| Casein sodium | Benzydamine hydrochloride | Buccal films | Pilicheva et al. [ | |
| Heparin and dextran sulfate | Transforming GF β1, platelet-derived GF ββ, and insulin-like growth factor 1 | Materials for tissue regeneration | Damanik et al. [ | |
| Poly(γ-glutamic acid) | Interferon-γ | Systems for gastric cancer treatment | Cardoso et al. [ | |
| β-cyclodextrin polymer | 4-tert-butylbenzoic acid | Medical devices with antibiotics or antiseptic agents | Martin et al. [ | |
| Gentamicin | Prevention of perioperative infections | Pérez-Anes et al. [ | ||
| Sodium salt of carboxymethyl cellulose | Fluorescein isothiocyanate, ovalbumin | Medical devices | Park et al. [ | |
| Pectin/Xanthan gum/Karaya gum | Tenofovir | Vaginal films | Martín-Illana et al. [ | |
| Eudragit E® | Hypromellose acetate succinate | Diclofenac sodium | Colon-specific tablets | Jeganathan et al. [ |
| Poly(4-vinylpyridine) | Sodium alginate | Ciprofloxacin hydrochloride | Transdermal systems | Alshhab et al. [ |
Figure 3Factors which should be taken into consideration in PEMs designing as potential drug delivery materials.
Figure 4PEMs composed of cationic Eudragit E® and anionic hypromellose acetate succinate (HPMCAS) as coatings for colon specific tablets.
Figure 5The possible utilization of PEMs in tissue engineering.